Targeting the PI3K/mTOR and ATR/Chk1 pathways to improve radiation efficacy for cancer therapy by Fokas, E

The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies by Fokas, E, Mckenna, W, Muschel, R

The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies. by Fokas, E, Mckenna, W, Muschel, R

A comparison of four target volume definitions for pancreatic cancer: Two concepts including the lymphatics (RTOG and German multi-centre neoadjuvant trial) and two concepts only t... by Fokas, E, Eccles, C, Mckenna, W, Brunner, T

In reply to Weiss et al. by Fokas, E, Henzel, M, Engenhart-Cabillic, R

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon? by Fokas, E, Fokas, E, Liersch, T, Fietkau, R, Hohenberger, W, Hess, C, Becker, H, Sauer, R, Wittekind, C, Rödel, C

Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancer... by Warren, S, Partridge, M, Fokas, E, Eccles, C, Brunner, T

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer by Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E

A Comparison of 4 Target Volume Definitions for Pancreatic Cancer: Two Concepts Including the Lymphatics (RTOG and ARO) and 2 Concepts Only Treating the Primary Tumor (Michigan and... by Brunner, T, Fokas, E, Eccles, C, Fenwick, J, McKenna, G

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma by Knight, J, Mosley, M, Bravo, L, Fokas, E, Cornelissen, B

A comprehensive comparison of IMAT and 3D-CRT plan quality for gastrointestinal organ sparing and NTCP using the Eclipse Radiobiological modelling software by Warren, S, Fokas, E, Partridge, M, Eccles, C, Mckenna, W, Brunner, T

Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients. by Fokas, E, Henzel, M, Surber, G, Hamm, K, Engenhart-Cabillic, R

Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients. by Fokas, E, Henzel, M, Surber, G, Hamm, K, Engenhart-Cabillic, R

Targeting ATR in DNA damage response and cancer therapeutics. by Fokas, E, Prevo, R, Hammond, E, Brunner, T, Mckenna, W, Muschel, R

A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy by Fokas, E, Eccles, C, Patel, N, Chu, K, Warren, S, Mckenna, W, Brunner, T

A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy. by Fokas, E, Eccles, C, Patel, N, Chu, K, Warren, S, Mckenna, W, Brunner, T

A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk by Fokas, E, Eccles, C, Patel, N, Chu, K, Warren, S, Mckenna, W, Brunner, T

Targeting ATR in DNA damage response and cancer therapeutics by Fokas, E, Prevo, R, Hammond, E, Brunner, T, McKenna, W, Muschel, R

GTP cyclohydrolase as a novel mechanism for tumour growth by Chen, L, Zhang, W, Leek, R, Buffa, F, Fokas, E, Harris, A, Cai, S

Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic. by Fokas, E, O'Neill, E, Gordon-Weeks, A, Mukherjee, S, McKenna, W, Muschel, R